NCT06570902View on ClinicalTrials.gov

Prospective WCD Post CABG Registry (CABG Registry)

RecruitingOBSERVATIONAL
Enrollment

910

Participants

Timeline

Start Date

September 23, 2024

Primary Completion Date

November 30, 2029

Study Completion Date

May 31, 2030

Conditions
Cardiomyopathy IschemicCardiomyopathiesCardiovascular DiseasesHeart Disease, Ischemic
Interventions
DEVICE

WCD

An FDA-approved, CE marked WCD will be prescribed for up to 3 months of use after hospital discharge, with the option for longer use under physician discretion

Trial Locations (4)

30625

RECRUITING

Medizinische Hochschule Hannover, Hanover

61231

NOT_YET_RECRUITING

Kerckhoff Klinik, Bad Nauheim

03048

RECRUITING

Sana-Herzzentrum Cottbus GmbH, Cottbus

06120

RECRUITING

Universitätsklinikum Halle (Saale), Halle

All Listed Sponsors
lead

Zoll Medical Corporation

INDUSTRY